Bosh sahifaRDY • NYSE
Dr Reddy's Laboratories Ltd
14,44 $
Seans yopilganidan keyin:
14,57 $
(0,90%)+0,13
Yopilgan:16-may, 16:36:01 (GMT-4) · USD · NYSE · Ogohlantirish
AQSH qimmatli qogʻoziBosh shtabi: IN
Yopilish kursi
14,39 $
Kunlik diapazon
14,27 $ - 14,46 $
Yillik diapazon
12,26 $ - 16,89 $
Bozor kapitalizatsiyasi
12,09 mlrd USD
Oʻrtacha hajm
2,43 mln
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(INR)mar, 2025Y/Y qiyosi
Daromad
85,06 mlrd20,09%
Joriy xarajat
30,40 mlrd13,94%
Sof foyda
15,94 mlrd21,95%
Sof foyda marjasi
18,741,57%
Har bir ulushga tushum
19,8427,69%
EBITDA
21,42 mlrd23,29%
Amaldagi soliq stavkasi
20,85%
Jami aktivlari
Jami passivlari
(INR)mar, 2025Y/Y qiyosi
Naqd pul va qisqa investitsiyalar
57,91 mlrd-28,92%
Jami aktivlari
492,99 mlrd27,22%
Jami passivlari
155,82 mlrd45,67%
Umumiy kapital
337,17 mlrd
Tarqatilgan aksiyalar
833,19 mln
Narxi/balansdagi bahosi
0,04
Aktivlardan daromad
8,66%
Kapitaldan daromad
11,14%
Naqd pulning sof oʻzgarishi
(INR)mar, 2025Y/Y qiyosi
Sof foyda
15,94 mlrd21,95%
Operatsiyalardan naqd pul
22,00 mlrd90,94%
Sarmoyadan naqd pul
-6,24 mlrd44,99%
Moliyadan naqd pul
-14,43 mlrd-2 606,57%
Naqd pulning sof oʻzgarishi
1,56 mlrd464,72%
Boʻsh pul
7,69 mlrd-3,61%
Haqida
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr. Wikipedia
Tashkil etilgan
1984
Xodimlar soni
27 048
Yana
Bu sizni qiziqtirishi mumkin
Bu roʻyxat oxirgi qidiruvlar, kuzatilgan aksiyalar va boshqa faoliyatdan tuzilgan. Batafsil

Barcha axborotlar faqat maʼlumot sifatida “shundayligicha” taqdim etilgan, ulardan moliyaviy maslahat sifatida foydalanmang, ular savdo maqsadlari yoki investitsiya, soliq, yuridik, buxgalteriya yoki boshqa turdagi maslahat emas. Google investitsiya borasida maslahatchi emas, bu roʻyxatdagi kompaniyalar yoki ularning aksiyalari borasida hech qanday nuqtai nazar, tavsiya yoki fikr bildirmaydi. Har qanday savdoni boshlashdan oldin broker yoki moliyaviy vakil bilan maslahatlashib, narxlarni tekshiring. Batafsil
Aloqador qidiruvlar
Qidiruv
Qidiruv maydonini tozalash
Qidiruvni yopish
Google ilovalari
Asosiy menyu